Interleukin 2 and low molecular weight B cell growth factor are T cell-replacing factors for different subpopulations of human B cells*

1988 ◽  
Vol 18 (10) ◽  
pp. 1635-1638 ◽  
Author(s):  
Robin E. Callard ◽  
Susan H. Smith
1983 ◽  
Vol 157 (1) ◽  
pp. 60-68 ◽  
Author(s):  
J L Butler ◽  
A Muraguchi ◽  
H C Lane ◽  
A S Fauci

The success of long-term culture of normal human and murine B cells has been hampered by the limited availability of soluble factors capable of maintaining proliferation of activated B lymphocytes. Previous experiments using various culture-derived supernatants in a human system were unable to separate the activities of B cell growth factor (BCGF) and interleukin 2 (IL-2) by immunochemical means. Thus, purified factors with BCGF activity in the absence of IL-2 activity have not been available for study. In the present study, normal human peripheral blood T cells were fused with the hypoxanthine/aminopterin/thymidine-sensitive human T-leukemic cell line, CEM-6. Supernatants from the resulting hybrid cells were tested for the ability to maintain proliferation of normal human B cells in a recently described assay system for human BCGF. Hybrids demonstrating BCGF activity were cloned by limiting dilution. One hybrid clone, 2B11, continued to support proliferation of B cells in both long-term cultures and 6-d assays at a level significantly above that seen with conventionally produced growth factors. No IL-2 activity was found in the supernatant from hybrid 2B11. The hybridoma supernatant was fractionated by gel filtration, and maximum proliferation of B cells was supported by the 18-20,000 mol wt protein fraction. Thus, a human T-T cell hybridoma that has BCGF activity in the absence of any demonstrable IL-2 activity has been developed. Human T-T cell hybridomas secreting discrete immunoregulatory factors should prove to be powerful tools in dissecting the mechanisms of immunoregulation of human lymphocyte function.


1988 ◽  
Vol 18 (2) ◽  
pp. 255-259 ◽  
Author(s):  
John G. Shields ◽  
Susan H. Smith ◽  
Stephan Strobel ◽  
Roland J. Levinsky ◽  
Thierry Defrance ◽  
...  

1985 ◽  
Vol 15 (12) ◽  
pp. 1158-1164 ◽  
Author(s):  
Sergio Romagnani ◽  
Grazia M. Giudizi ◽  
Enrico Maggi ◽  
Fabio Almerigogna ◽  
Roberta Biagiotti ◽  
...  

1982 ◽  
Vol 155 (3) ◽  
pp. 914-923 ◽  
Author(s):  
M Howard ◽  
J Farrar ◽  
M Hilfiker ◽  
B Johnson ◽  
K Takatsu ◽  
...  

We report here a factor (B cell growth factor) found in induced supernatants of the mouse thymoma EL4 that co-stimulates with anti-IgM antibodies in short-term cultures of purified B lymphocytes to induce polyclonal B cell proliferation but not antibody-forming cell production. The factor is not mitogenic for resting B cells and interacts with anti-IgM-activated B cells in a non-H-2-restricted manner. Absorption studies and molecular weight analysis reveal the factor is distinct from interleukin 2. This factor synergises with antigen, interleukin 2, and an interleukin 2-free, B cell growth factor-free T cell supernatant that contains T cell-replacing factor to produce erythrocyte-specific plaque-forming cells in cultures of highly purified B cells.


1989 ◽  
Vol 170 (5) ◽  
pp. 1477-1493 ◽  
Author(s):  
R H DeKruyff ◽  
T Turner ◽  
J S Abrams ◽  
M A Palladino ◽  
D T Umetsu

We have analyzed in detail the precise requirements for the induction of human IgE synthesis using several experimental approaches with purified B cells and well-characterized alloantigen-specific CD4+ T cell clones expressing different profiles of lymphokine secretion. Using these clones under cognate conditions in which the B cells expressed alloantigens recognized by the cloned T cells, we have confirmed that IL-4 is required for the induction of IgE synthesis, but we have clearly demonstrated that IL-4 by itself is not sufficient. With several cloned CD4+ T cell lines, including an IL-4-producing clone that could not induce IgE synthesis, and cloned T cells pretreated with cyclosporin A to inhibit lymphokine synthesis, we showed that Th cell-B cell interactions are necessary for IgE synthesis, and that low molecular weight B cell growth factor (LMW-BCGF) and IL-4, in combination, are lymphokines of major importance in the induction of IgE synthesis. Together our results indicate that optimal induction of an IgE-specific response requires the exposure of B cells to a particular complex of signals that include (a) a signal(s) involving Th-B cell interaction that primes B cells to receive additional signals from soluble lymphokines, (b) a specific B cell proliferative signal provided by LMW-BCGF, and (c) a specific B cell differentiation signal provided by IL-4.


1986 ◽  
Vol 16 (12) ◽  
pp. 1503-1507 ◽  
Author(s):  
Aime Vazquez ◽  
Jean-Philipe Gerard ◽  
Daniel Olive ◽  
Marie-Thérèse Auffredou ◽  
Bernard Dugas ◽  
...  

1988 ◽  
Vol 21 (3) ◽  
pp. 155-164
Author(s):  
Wayne M. Yokoyama ◽  
Millie M. Chien ◽  
Susan E. Engardt ◽  
Susan W. Aguiar ◽  
Robert F. Ashman

1985 ◽  
Vol 162 (4) ◽  
pp. 1319-1335 ◽  
Author(s):  
J L Ambrus ◽  
C H Jurgensen ◽  
E J Brown ◽  
A S Fauci

High molecular weight B cell growth factor (HMW-BCGF) produced by a T cell line was purified to homogeneity and demonstrated to bind specifically to activated human B cells. A monoclonal antibody to HMW-BCGF was developed that (a) specifically inhibited the activity of HMW-BCGF in enhancing B cell proliferation, (b) specifically bound to HMW-BCGF in Western blots, (c) specifically absorbed HMW-BCGF activity from culture supernatants, and (d) specifically absorbed an internally labeled protein from T-ALL supernatant which comigrates with HMW-BCGF on sodium dodecyl sulfate-polyacrylamide gels. This antibody should help in cloning the gene for HMW-BCGF and further exploring the physiologic roles of HMW-BCGF.


1983 ◽  
Vol 80 (16) ◽  
pp. 5047-5051 ◽  
Author(s):  
A. L. Maizel ◽  
J. W. Morgan ◽  
S. R. Mehta ◽  
N. M. Kouttab ◽  
J. M. Bator ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document